RESUMEN
Testosterone is a sex hormone involved in brain maturation via multiple molecular mechanisms. Previous human studies described age-related changes in the overall volume and structural properties of white matter during male puberty. Based on this work, we have proposed that testosterone may induce a radial growth of the axon and, possibly, modulate axonal transport. In order to determine whether this is the case we have used two different experimental approaches. With electron microscopy, we have evaluated sex differences in the structural properties of axons in the corpus callosum (splenium) of young rats, and tested consequences of castration carried out after weaning. Then we examined in vitro the effect of the non-aromatizable androgen Mibolerone on the structure and bidirectional transport of wheat-germ agglutinin vesicles in the axons of cultured sympathetic neurons. With electron microscopy, we found robust sex differences in axonal diameter (males>females) and g ratio (males>females). Removal of endogenous testosterone by castration was associated with lower axon diameter and lower g ratio in castrated (vs. intact) males. In vitro, Mibolerone influenced the axonal transport in a time- and dose-dependent manner, and increased the axon caliber as compared with vehicle-treated neurons. These findings are consistent with the role of testosterone in shaping the axon by regulating its radial growth, as predicted by the initial human studies.
Asunto(s)
Andrógenos/farmacología , Transporte Axonal/efectos de los fármacos , Transporte Axonal/fisiología , Axones/efectos de los fármacos , Axones/ultraestructura , Animales , Cuerpo Calloso/efectos de los fármacos , Cuerpo Calloso/ultraestructura , Relación Dosis-Respuesta a Droga , Femenino , Inmunohistoquímica , Masculino , Nandrolona/análogos & derivados , Nandrolona/farmacología , Orquiectomía , Ovariectomía , Cultivo Primario de Células , Ratas , Ratas Wistar , Caracteres Sexuales , Testosterona/farmacología , Sustancia Blanca/anatomía & histología , Sustancia Blanca/efectos de los fármacosRESUMEN
The p53 family members p73 and p63 have been implicated in various aspects of stem cell regulation. Here, we have asked whether they work together to regulate stem cell biology, focusing upon neural precursor cells (NPCs) in the adult murine brain. By studying mice that are haploinsufficient for p63 and/or p73, we show that these two proteins cooperate to ensure appropriate NPC self-renewal and long-term maintenance in the hippocampus and forebrain, and that when both are haploinsufficient, the NPC deficits are significantly greater than haploinsufficiency for either alone. We show that, in the case of p63(+/-) mice, this decrease in adult NPCs is caused by enhanced apoptosis. However, when p73 is coincidently haploinsufficient, this rescues the enhanced apoptosis of p63(+/-) NPCs under both basal conditions and following genotoxic stress, instead causing increased cellular senescence. This increase in cellular senescence is likely due, at least in part, to increased levels of basal DNA damage and p53 activation, as genetic ablation of p53 completely rescues the senescence phenotype observed in p63(+/-); p73(+/-) mice. Thus, the presence of p73 determines whether p63(+/-) NPCs exhibit increased p53-dependent apoptosis or senescence. Together, these studies demonstrate that p63 and p73 cooperate to maintain adult NPC pools through regulation of p53 function; p63 antagonizes p53 to promote cellular survival, whereas p73 regulates self-renewal and p53-mediated apoptosis versus senescence.
Asunto(s)
Apoptosis/genética , Proteínas de Unión al ADN/genética , Células-Madre Neurales/fisiología , Proteínas Nucleares/genética , Fosfoproteínas/genética , Transactivadores/genética , Proteína p53 Supresora de Tumor/metabolismo , Proteínas Supresoras de Tumor/genética , Animales , Supervivencia Celular , Senescencia Celular/genética , Daño del ADN/genética , Proteínas de Unión al ADN/metabolismo , Haploinsuficiencia , Hipocampo/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Prosencéfalo/metabolismo , Proteína Tumoral p73RESUMEN
Myelin-associated glycoprotein (MAG) is a well-characterized axon growth inhibitor in the adult vertebrate nervous system. Several signals that play roles in inhibiting axon growth have been identified. Here, we report that soluble MAG induces activation of Rap1 in postnatal cerebellar granule neurons (CGNs) and dorsal root ganglion (DRG) neurons. The p75 receptor associates with activated Rap1 and is internalized in response to MAG. After MAG is applied to the distal axons of the sciatic nerves, the activated Rap1, internalized p75 receptor, and MAG are retrogradely trafficked via axons to the cell bodies of the DRG neurons. Rap1 activity is required for survival of the DRG neurons as well as CGNs when treated with MAG. The transport of the signaling complex containing the p75 receptor and Rap1 may play a role in the effect of MAG.
Asunto(s)
Glicoproteína Asociada a Mielina/fisiología , Neuronas/metabolismo , Receptor de Factor de Crecimiento Nervioso/metabolismo , Transducción de Señal , Proteínas de Unión al GTP rap1/metabolismo , Animales , Axones/efectos de los fármacos , Axones/metabolismo , Células Cultivadas , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/metabolismo , Humanos , Ratones , Ratones Endogámicos C57BL , Glicoproteína Asociada a Mielina/farmacología , Neuronas/efectos de los fármacos , Ratas , Proteínas RecombinantesAsunto(s)
Proteínas de Unión al ADN/fisiología , Neoplasias/fisiopatología , Sistema Nervioso/crecimiento & desarrollo , Proteínas Nucleares/fisiología , Animales , Apoptosis/fisiología , Supervivencia Celular/fisiología , Proteínas de Unión al ADN/genética , Genes Supresores de Tumor , Humanos , Neoplasias/tratamiento farmacológico , Neoplasias/genética , Fenómenos Fisiológicos del Sistema Nervioso , Neuronas/fisiología , Proteínas Nucleares/genética , Isoformas de Proteínas/química , Isoformas de Proteínas/genética , Isoformas de Proteínas/fisiología , Proteínas Proto-Oncogénicas/fisiología , Proteína Tumoral p73 , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/fisiología , Proteínas Supresoras de Tumor/fisiologíaRESUMEN
A disease with symptoms similar to elm yellows (EY) was noticed in the early 1990s in suburban Chicago, IL. More than 1,000 mature American elms (Ulmus americana) have since died. Infected trees varied in the incidence and severity of canopy yellowing, leaf epinasty, butterscotch discoloration, and wintergreen odor of the phloem, but all developed a sparse and clumpy crown, uniformly necrotic phloem, and died within 2 years of showing canopy symptoms. Because symptoms were expressed irregularly and phytoplasma detection results by a commercial diagnostic company were inconsistent, a study was initiated to determine if EY phytoplasma was the causal agent. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods using universal or EY phytoplasma specific primers were employed to detect putative phytoplasma(s) associated with 10 trees of varied disease severity within the outbreak region and 10 asymptomatic trees from an uninfected area (controls). Nested PCR using universal primers revealed that 90% of trees from the outbreak region were positive for phytoplasma while asymptomatic elms from another location (controls) tested negative. Phytoplasma-positive trees ranged in disease severity from 1 (asymptomatic) to 5 (near death). Inner bark samples chiseled from the lower trunk had higher phytoplasma detection rates than foliage or drill shavings. RFLP analyses and DNA sequencing of 16S rDNA indicated that the phytoplasma recovered from dying elms in Arlington Heights is not related to the reference EY phytoplasma (group16SrV). It is most closely related to clover proliferation (CP) phy-toplasma (group 16SrVI), and we have designated it Illinois Elm Yellows (ILEY) phytoplasma, and assigned it to a new taxonomic subgroup (16SrVI-C). EY phytoplasma was not detected in any samples, but two ILEY phytoplasma positive trees also were positive for aster yellows (AY) phytoplasma. ILEY phytoplasma was not detected in local leafhopper populations trapped in elm trees between May and September 2000. This is the first report of a phytoplasma related to CP phytoplasma causing elm yellows disease symptoms.
RESUMEN
Target-derived neurotrophins like nerve growth factor (NGF) mediate biological effects by binding to and activating Trk neurotrophin receptors at nerve terminals. The activated Trk receptors then stimulate local effects at nerve terminals, and retrograde effects at neuronal cell bodies that often reside at considerable distances from the terminals. However, the nature of the retrograde signal has been mysterious. Recent experiments suggest that the major retrograde signal required for survival and gene expression consists of activated Trk itself. Remarkably, signaling by Trk may differ at the terminal versus the neuronal cell body as a consequence of the retrograde transport mechanism, thereby allowing NGF to not only promote growth locally, but to specifically support survival and gene expression retrogradely.
Asunto(s)
Transporte Axonal/fisiología , Factor de Crecimiento Nervioso/metabolismo , Receptor trkA/fisiología , Transducción de Señal/fisiología , Animales , Activación Enzimática/fisiología , Humanos , Receptores de Factor de Crecimiento Nervioso/fisiologíaRESUMEN
Recent evidence indicates that naturally occurring neuronal death in mammals is regulated by the interplay between receptor-mediated prosurvival and proapoptotic signals. The neurotrophins, a family of growth factors best known for their positive effects on neuronal biology, have now been shown to mediate both positive and negative survival signals, by signalling through the Trk and p75 neurotrophin receptors, respectively. The mechanisms whereby these two neurotrophin receptors interact to determine neuronal survival have been difficult to decipher, largely because both can signal independently or coincidentally, depending upon the cell or developmental context. Nonetheless, the past several years have seen significant advances in our understanding of this receptor signalling system. In this review, we focus on the proapoptotic actions of the p75 neurotrophin receptor (p75NTR), and on the interplay between Trk and p75NTR that determines neuronal survival.
Asunto(s)
Apoptosis , Factores de Crecimiento Nervioso/metabolismo , Neuronas/citología , Receptor trkA/metabolismo , Receptores de Factor de Crecimiento Nervioso/metabolismo , Transducción de Señal , Animales , Humanos , Factores de Crecimiento Nervioso/fisiología , Receptor de Factor de Crecimiento Nervioso , Receptor trkA/genética , Receptor trkA/fisiologíaRESUMEN
We describe here the isolation of stem cells from juvenile and adult rodent skin. These cells derive from the dermis, and clones of individual cells can proliferate and differentiate in culture to produce neurons, glia, smooth muscle cells and adipocytes. Similar precursors that produce neuron-specific proteins upon differentiation can be isolated from adult human scalp. Because these cells (termed SKPs for skin-derived precursors) generate both neural and mesodermal progeny, we propose that they represent a novel multipotent adult stem cell and suggest that skin may provide an accessible, autologous source of stem cells for transplantation.
Asunto(s)
Diferenciación Celular/fisiología , Sistema Nervioso/citología , Piel/citología , Células Madre/citología , Células Madre/fisiología , Adipocitos/citología , Envejecimiento , Animales , Animales Recién Nacidos , Técnicas de Cultivo de Célula , División Celular , Células Clonales , Humanos , Ratones , Ratones Transgénicos , Músculo Liso/citología , Neuroglía/citología , Neuronas/citología , Regiones Promotoras Genéticas , Piel/crecimiento & desarrollo , Tubulina (Proteína)/genética , beta-Galactosidasa/análisis , beta-Galactosidasa/genéticaRESUMEN
Duchenne Muscular Dystrophy (DMD) originates from deleterious mutations in the dystrophin gene, with a complete loss of the protein product. Subsequently, the disease is manifested in severe striated muscle wasting and death in early adulthood. Dystrophin provides a structural base for the assembly of an integral membrane protein complex. As such, dystrophin deficiency leads to an altered mechanical integrity of the myofiber and a predisposition to contraction-induced damage. However, the development of myofiber degeneration prior to an observed mechanical defect has been documented in various dystrophic models. Although activation of a detrimental signal transduction pathway has been suggested as a probable cause, a specific cellular cascade has yet to be defined. Here, it is shown that murine models of DMD displayed a muscle-specific activation of JNK1. Independent activation of JNK1 resulted in defects in myotube viability and integrity in vitro, similar to a dystrophic phenotype. In addition, direct muscle injection of an adenoviral construct containing the JNK1 inhibitory protein, JIP1, dramatically attenuated the progression of dystrophic myofiber destruction. Taken together, these results suggest that a JNK1-mediated signal cascade is a conserved feature of dystrophic muscle and contributes to the progression of the disease pathogenesis.
Asunto(s)
Proteínas Quinasas Activadas por Mitógenos/metabolismo , Músculo Esquelético/patología , Distrofia Muscular de Duchenne/enzimología , Distrofia Muscular de Duchenne/patología , Adenoviridae/genética , Animales , Células Cultivadas , Activación Enzimática , Proteínas Fluorescentes Verdes , Humanos , Indicadores y Reactivos/metabolismo , Proteínas Luminiscentes/metabolismo , Sistema de Señalización de MAP Quinasas , Ratones , Ratones Endogámicos mdx , Ratones Transgénicos , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos , Proteína Quinasa 8 Activada por Mitógenos , Proteínas Quinasas Activadas por Mitógenos/genética , Músculo Esquelético/enzimología , Músculo Esquelético/metabolismo , Distrofia Muscular Animal/enzimología , Distrofia Muscular Animal/genética , Distrofia Muscular Animal/patología , Distrofia Muscular de Duchenne/genética , Miocardio/enzimología , Miocardio/metabolismo , Miocardio/patología , Fosforilación , TransfecciónRESUMEN
Converging lines of evidence implicate the beta-amyloid peptide (Ass) as causative in Alzheimer's disease. We describe a novel class of compounds that reduce A beta production by functionally inhibiting gamma-secretase, the activity responsible for the carboxy-terminal cleavage required for A beta production. These molecules are active in both 293 HEK cells and neuronal cultures, and exert their effect upon A beta production without affecting protein secretion, most notably in the secreted forms of the amyloid precursor protein (APP). Oral administration of one of these compounds, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, to mice transgenic for human APP(V717F) reduces brain levels of Ass in a dose-dependent manner within 3 h. These studies represent the first demonstration of a reduction of brain A beta in vivo. Development of such novel functional gamma-secretase inhibitors will enable a clinical examination of the A beta hypothesis that Ass peptide drives the neuropathology observed in Alzheimer's disease.
Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Encéfalo/metabolismo , Dipéptidos/administración & dosificación , Endopeptidasas/metabolismo , Administración Oral , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/genética , Secretasas de la Proteína Precursora del Amiloide , Precursor de Proteína beta-Amiloide/genética , Precursor de Proteína beta-Amiloide/metabolismo , Animales , Ácido Aspártico Endopeptidasas , Encéfalo/citología , Encéfalo/efectos de los fármacos , Células Cultivadas , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Endopeptidasas/efectos de los fármacos , Inhibidores Enzimáticos/administración & dosificación , Femenino , Humanos , Inyecciones Subcutáneas , Riñón/citología , Riñón/efectos de los fármacos , Riñón/metabolismo , Masculino , Ratones , Ratones Transgénicos , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Fragmentos de Péptidos/metabolismoAsunto(s)
Ratones Transgénicos , Factores de Crecimiento Nervioso/genética , Receptores de Factor de Crecimiento Nervioso/genética , Animales , Southern Blotting/métodos , Western Blotting/métodos , Encéfalo/metabolismo , ADN/aislamiento & purificación , Enzimas de Restricción del ADN/química , Expresión Génica , Inmunohistoquímica/métodos , Ratones , Factores de Crecimiento Nervioso/biosíntesis , Factores de Crecimiento Nervioso/aislamiento & purificación , Neuronas/metabolismo , Regiones Promotoras Genéticas , Sondas ARN , ARN Mensajero/biosíntesis , ARN Mensajero/aislamiento & purificación , Receptores de Factor de Crecimiento Nervioso/biosíntesis , Receptores de Factor de Crecimiento Nervioso/aislamiento & purificación , TransgenesRESUMEN
Developmental sympathetic neuron death is determined by functional interactions between the TrkA/NGF receptor and the p75 neurotrophin receptor (p75NTR). A key question is whether p75NTR promotes apoptosis by directly inhibiting or modulating TrkA activity, or by stimulating cell death independently of TrkA. Here we provide evidence for the latter model. Specifically, experiments presented here demonstrate that the presence or absence of p75NTR does not alter Trk activity or NGF- and NT-3-mediated downstream survival signaling in primary neurons. Crosses of p75NTR-/- and TrkA-/- mice indicate that the coincident absence of p75NTR substantially rescues TrkA-/- sympathetic neurons from developmental death in vivo. Thus, p75NTR induces death regardless of the presence or absence of TrkA expression. These data therefore support a model where developing sympathetic neurons are "destined to die" by an ongoing p75NTR-mediated apoptotic signal, and one of the major ways that TrkA promotes neuronal survival is by silencing this ongoing death signal.
Asunto(s)
Supervivencia Celular/fisiología , Neuronas/citología , Proteínas Oncogénicas/metabolismo , Receptores de Factor de Crecimiento Nervioso/metabolismo , Animales , Células Cultivadas , Ratones , Ratones Endogámicos BALB C , Neuronas/metabolismo , Receptor de Factor de Crecimiento Nervioso , Transducción de SeñalRESUMEN
The retinoblastoma tumor suppressor protein (pRb) family is essential for cortical progenitors to exit the cell cycle and survive. In this report, we test the hypothesis that pRb collaborates with basic helix-loop-helix (bHLH) transcription factors to regulate cortical neurogenesis, taking advantage of the naturally occurring dominant-inhibitory HLH protein Id2. Overexpression of Id2 in cortical progenitors completely inhibited the induction of neuron-specific genes and led to apoptosis, presumably as a consequence of conflicting differentiation signals. Both of these phenotypes were rescued by coexpression of a constitutively activated pRb mutant. In contrast, Id2 overexpression in postmitotic cortical neurons affected neither neuronal gene expression nor survival. Thus, pRb collaborates with HLHs to ensure the coordinate induction of terminal mitosis and neuronal gene expression as cortical progenitors become neurons.
Asunto(s)
Corteza Cerebral/metabolismo , Secuencias Hélice-Asa-Hélice/fisiología , Neuronas/metabolismo , Proteínas Represoras , Proteína de Retinoblastoma/metabolismo , Factores de Transcripción/metabolismo , Adenoviridae/genética , Animales , Apoptosis , Diferenciación Celular/fisiología , Supervivencia Celular/fisiología , Células Cultivadas , Corteza Cerebral/citología , Corteza Cerebral/embriología , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Proteínas de Unión al ADN/farmacología , Expresión Génica/efectos de los fármacos , Vectores Genéticos/genética , Vectores Genéticos/metabolismo , Etiquetado Corte-Fin in Situ , Proteína 2 Inhibidora de la Diferenciación , Ratones , Neuronas/citología , Células Madre/citología , Células Madre/metabolismo , Transfección , Tubulina (Proteína)/metabolismoRESUMEN
To determine how signals emanating from Trk transmit neurotrophin actions in primary neurons, we tested the ability of TrkB mutated at defined effector binding sites to promote sympathetic neuron survival or local axon growth. TrkB stimulated signaling proteins and induced survival and growth in a manner similar to TrkA. TrkB mutated at the Shc binding site supported survival and growth poorly relative to wild-type TrkB, whereas TrkB mutated at the PLC-gamma1 binding site supported growth and survival well. TrkB-mediated neuronal survival was dependent on P13-kinase and to a lesser extent MEK activity, while growth depended upon both MEK and P13-kinase activities. These results indicate that the TrkB-Shc site mediates both neuronal survival and axonal outgrowth by activating the P13-kinase and MEK signaling pathways.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Proteínas Adaptadoras del Transporte Vesicular , Axones/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Neuronas/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas/metabolismo , Proteínas Proto-Oncogénicas , Receptor trkB/genética , Transducción de Señal/fisiología , Adenoviridae/genética , Fibras Adrenérgicas/metabolismo , Animales , Animales Recién Nacidos , Sitios de Unión/genética , Supervivencia Celular/genética , Células Cultivadas , Vectores Genéticos/biosíntesis , Vectores Genéticos/genética , Isoenzimas/metabolismo , Neuronas/citología , Fosfolipasa C gamma , Fosforilación , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt , Ratas , Ratas Sprague-Dawley , Receptor trkB/metabolismo , Proteínas Adaptadoras de la Señalización Shc , Transducción de Señal/genética , Proteína Transformadora 1 que Contiene Dominios de Homología 2 de Src , Fosfolipasas de Tipo C/metabolismo , Tirosina/metabolismoRESUMEN
p53 plays an essential pro-apoptotic role, a function thought to be shared with its family members p73 and p63. Here, we show that p73 is primarily present in developing neurons as a truncated isoform whose levels are dramatically decreased when sympathetic neurons apoptose after nerve growth factor (NGF) withdrawal. Increased expression of truncated p73 rescues these neurons from apoptosis induced by NGF withdrawal or p53 overexpression. In p73-/- mice, all isoforms of p73 are deleted and the apoptosis of developing sympathetic neurons is greatly enhanced. Thus, truncated p73 is an essential anti-apoptotic protein in neurons, serving to counteract the pro-apoptotic function of p53.
Asunto(s)
Apoptosis/fisiología , Proteínas de Unión al ADN/fisiología , Neuronas/fisiología , Proteínas Nucleares/fisiología , Sistema Nervioso Simpático/fisiología , Proteína p53 Supresora de Tumor/fisiología , Adenoviridae/genética , Animales , Células Cultivadas , Proteínas de Unión al ADN/biosíntesis , Proteínas de Unión al ADN/química , Escherichia coli , Genes Supresores de Tumor , Humanos , Ratones , Ratones Endogámicos BALB C , Factor de Crecimiento Nervioso/farmacología , Proteínas Nucleares/biosíntesis , Proteínas Nucleares/química , Isoformas de Proteínas/biosíntesis , Isoformas de Proteínas/química , Isoformas de Proteínas/fisiología , Proteínas Recombinantes , Sistema Nervioso Simpático/citología , Proteína Tumoral p73 , Proteína p53 Supresora de Tumor/antagonistas & inhibidores , Proteínas Supresoras de TumorRESUMEN
Neurotrophins use two types of receptors, the Trk tyrosine kinase receptors and the p75 neurotrophin receptor (p75NTR), to regulate the growth, development, survival and repair of the nervous system. These receptors can either collaborate with or inhibit each other's actions to mediate neurotrophin effects. The development and survival of neurons is thus based upon the functional interplay of the signals generated by Trk and p75NTR. In the past two years, the signaling pathways used by these receptors, including Akt and MAPK-induced signaling via Trk, and JNK, p53, and NF-kappaB signaling via p75NTR, have been identified. In addition, a number of novel p75NTR-interacting proteins have been identified that transmit growth, survival, and apoptotic signals.
Asunto(s)
Factores de Crecimiento Nervioso/fisiología , Fenómenos Fisiológicos del Sistema Nervioso , Neuronas/fisiología , Transducción de Señal/fisiología , AnimalesRESUMEN
This supplement is a report on the Epidemiology 1, 2, 3 (EPI 1, 2, 3) investigation, its origins, evolution, and findings that were carried out over a period beginning in 1990 and ending in 1994 in Egypt. The large scope and size of the study, the largest to date on schistosomiasis in Egypt, was a rationale for publishing a supplement to document EPI 1, 2, 3 methods and results collectively in sufficient detail to serve as a reference for planning, designing, and analyzing future epidemiologic studies and evaluation of schistosomiasis control in Egypt. The 3 objectives of EPI 1, 2, 3 were to 1) determine the changing patterns of Schistosoma haematobium and S. mansoni, 2) investigate factors contributing to differences between villages in the Nile Delta, Middle Egypt, and Upper Egypt, and 3) investigate risk factors for morbidity. The objectives were addressed using standardized techniques, stool and urine examinations, clinical examinations (including abdominal ultrasound), and questionnaires on a selected sample of the populations of selected villages in 9 governorates in Egypt.
Asunto(s)
Esquistosomiasis Urinaria/epidemiología , Esquistosomiasis mansoni/epidemiología , Egipto/epidemiología , Estudios Epidemiológicos , Humanos , Incidencia , Morbilidad , Proyectos Piloto , PrevalenciaRESUMEN
Bad sample designs and selection bias have plagued studies on schistosomiasis, and as a result some believe that schistosomiasis is too focal, making it difficult to draw reliable samples. The Epidemiology 1, 2, 3 (EPI 1, 2, 3) sample design, although complex, demonstrates that sampling theory is readily applicable to epidemiologic studies of schistosomiasis. The EPI 1, 2, 3 sampling scheme was designed to achieve the smallest feasible standard errors given EPI 1, 2, 3 objectives and certain logistical constraints. The sample design is a multi-stage selection of villages (ezbas, which were stratified by size) and households within each of 9 purposely selected Egyptian governorates. Villages and households were systemically selected from census frames. The sampling of ezbas was especially difficult because of the lack of complete sampling frames and their wide variation in population size. Ultimately, ezbas were stratified by size and then randomly selected from each stratum. Sample sizes for villages and ezbas and individuals within ezbas were calculated based on EPI 1 and 2 objectives, respectively. No re-selection was made for non-respondents. A 20% subsample of the full sample was drawn for clinical and ultrasonographic examinations. The sample selected from individual governorates closely parallel the age structure of the 1986 census of the respective rural populations. Details of the study design and related methods are given below.